Ajanta Pharma Limited (BOM:532331)
India · Delayed Price · Currency is INR 3,383.95
+17.50 (0.52%)
At close: Jul 27, 2026
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 417.42 billion as of July 28, 2026. Its market cap has increased by 20.04% in one year.
Market Cap
417.42B
Enterprise Value
413.38B
Revenue
54.53B
Ranking
n/a
PE Ratio
39.53
Stock Price
3,383.95
ChartMarket Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 417.42B, an increase of 73,676.62%. That is a compound annual growth rate of 31.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 417.42B | 20.71% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.10T |
| Dr. Reddy's Laboratories | 958.68B |
| Abbott India | 595.05B |
| GlaxoSmithKline Pharmaceuticals | 425.76B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 256.35B |
| Granules India | 208.78B |
| AstraZeneca Pharma India | 204.20B |